Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Agenus Inc. (AGEN)

-NasdaqCM
8.61 Down 0.17(1.94%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:8.78
Open:8.84
Bid:7.98 x 1000
Ask:8.86 x 400
1y Target Est:11.60
Beta:-0.5
Earnings Date:Jul 22 - Jul 27 (Est.)
Day's Range:8.47 - 8.90
52wk Range:2.56 - 10.16
Volume:1,036,341
Avg Vol (3m):1,931,650
Market Cap:724.60M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AGENDown 1.94%724.60M
ABPI 0.00%N/A
DNDN 0.00%0.00

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):61.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.67
Quarterly EPS Est (Jun-15) :-0.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback